ADN - Advent Technologies Holdings, Inc.
NASDAQ
->
Utilities
->
Utilities—Renewable
Boston,
United States
Type: Equity
ADN price evolution
ADN
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2.48 | $2.21 | $1.23 | $3.1 |
| Inventory | $1.99 | $2.08 | $2.71 | $13.9 |
| Total current assets | $6.92 | $7.23 | $8.84 | $23.5 |
| Long term investments | ||||
| Property, plant & equipment | $7.08 | $23.8 | $24.77 | $28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $14.37 | $32.15 | $34.74 | $55.4 |
| Current liabilities | ||||
| Accounts payable | $6.28 | $5.68 | $5.09 | $6.1 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $15.78 | $17.26 | $11.91 | $12.8 |
| Long term debt | $0.54 | |||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $17.25 | $26.07 | $21.29 | $22.8 |
| Shareholders' equity | ||||
| Retained earnings | -$199.79 | -$188.51 | -$179.16 | -$153.4 |
| Other shareholder equity | -$2.36 | -$2.41 | -$2.33 | -$2.8 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.02 | |||
| Short term investments | ||||
| Net receivables | $1.23 | $3.2 | $9.19 | $1 |
| Inventory | $2.71 | $12.62 | $6.96 | $0.1 |
| Total current assets | $8.84 | $49.5 | $97.35 | $0.58 |
| Long term investments | ||||
| Property, plant & equipment | $24.77 | $21.99 | $8.58 | $0.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $93.34 | |||
| Total investments | ||||
| Total assets | $34.74 | $89.59 | $163.03 | $93.92 |
| Current liabilities | ||||
| Accounts payable | $5.09 | $3.48 | $3.64 | $0.35 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $11.91 | $13.67 | $18.87 | $3.18 |
| Long term debt | $0.14 | $0.04 | ||
| Total noncurrent liabilities | $117.18 | |||
| Total debt | ||||
| Total liabilities | $21.29 | $25.44 | $32.83 | $120.36 |
| Shareholders' equity | ||||
| Retained earnings | -$179.16 | -$107.76 | -$33.42 | -$79.98 |
| Other shareholder equity | -$2.33 | -$2.6 | -$1.27 | -$0 |
| Total shareholder equity | ||||
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.81 | $3.45 | $1.51 | $1.26 |
| Cost of revenue | ||||
| Gross Profit | $0.65 | $2.43 | -$10.94 | -$1.19 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $9.28 | $6.74 | $11.06 | $10.46 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.06 | -$0 | -$0.08 | |
| Interest expense | -$0.21 | -$0.24 | -$0.05 | -$0.01 |
| Net income | ||||
| Net income | -$11.27 | -$9.36 | -$25.73 | -$11.85 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4.86 | $7.84 | ||
| Cost of revenue | ||||
| Gross Profit | -$13.43 | -$0.74 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $43.45 | $48.13 | $1.63 | |
| Operating income | -$1.63 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.72 | -$1.97 | $0.2 | |
| Interest expense | $0.17 | -$0.04 | ||
| Net income | ||||
| Net income | -$71.4 | -$74.34 | -$100.21 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $0.27 | -$0.03 | -$6.23 | -$6.34 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $0.82 | $0.13 | $9.06 | $5.49 |
| Effect of exchange rate | -$0.01 | -$0.01 | $0.08 | $0.01 |
| Change in cash and equivalents | -$3.73 | -$2.79 | -$29.21 | -$27.19 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | -$100.21 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$3.2 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$6.23 | -$14.52 | -$25.56 | $132.93 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $9.06 | -$0.04 | $141.5 | -$130.22 |
| Effect of exchange rate | $0.08 | $0.54 | -$0.86 | |
| Change in cash and equivalents | -$29.21 | -$46.14 | $79.24 | -$0.5 |
News
Fundamentals
| Market cap | $1.27M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 2.64M |
| Revenue | $7.03M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$58.21M |
| Revenue Q/Q | -66.44% |
| Revenue Y/Y | N/A |
| P/E ratio | -0.02 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.18 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$22.08 |
|---|---|
| ROA | -170.37% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.44 |
| Quick ratio | 0.31 |